Protek headed for its lowest level in more than a week Friday after the Federal Anti-Monopoly Service said it will investigate charges that the pharmaceutical wholesaler and 17 others companies rigged government drug-supply tenders.
The stock fell as much as 3.1 percent and last traded 2 percent lower at 41.72 rubles as of 12:15 a.m. in Moscow. A close at that price would be its weakest since April 5. The regulator said 18 manufacturers, including Protek and Pharmstandard, are suspected of illegally colluding in tenders in 2008 and 2009.
Pharmstandard fell for a second day, losing 0.8 percent and closing around 2,600 rubles.
(Bloomberg)
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
